2020
Dronin-Fenton D, Dalvi T, Movva N , Pedersen I, Hansen H, Fryzek J, Mellemgaard A, Rasmussen T, et al. PD-L1 expression and survival in stage III unresectable non-small cell lung cancer patients in Denmark. Abstract #2865, European Society for Medical Oncology (ESMO), Virtual, August 2020.
View Abstract
Publication: Abstracts and Presentations
Elbeddini A, Hooda N , Gazarin M, Webster P, McMillan J. 2020. Irinotecan-associated dysarthria in patients with pancreatic cancer: A single site experience. Am J Case Rep 21:e924058; doi: 10.12659/AJCR.924058 . PMID: 32594093.
View Abstract
Publication: Manuscripts
Jensen IS , Hathway J, Cyr PL , Gauden D, Gardiner P. 2020. Cost–consequence analysis of 18 F-fluciclovine for the staging of recurrent prostate cancer. J Mark Access Health Pol 8(1):1749362; doi: 10.1080/20016689.2020.1749362 .
View Abstract
Publication: Manuscripts
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Jena A, et al. 2020. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives. J Med Econ 23(6):581-592; doi: 10.1080/13696998.2020.1730123 .
View Abstract
Publication: Manuscripts
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Yao W, et al. Budget impact of improving adherence to colorectal cancer screening. Abstract PCN148 , ISPOR 2020.
View Abstract
Publication: Abstracts and Presentations
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Yao W, et al. The impact of increasing mt-sDNA use among colorectal cancer screeners in a US employer population. Abstract PCN145 , ISPOR 2020.
View Abstract
Publication: Abstracts and Presentations
Cohen S, Reichert H , Kansal AR, Chung KC. Improved efficiency of cancer screening with multi-cancer early detection test. International Society for Pharmacoeconomics and Outcomes Research, Inc. (ISPOR) Virtual Conference, May 2020.
Publication: Abstracts and Presentations
Menon N, Leslie TF, Frankenfeld CL . 2020. Cancer-related diagnostic and treatment capabilities of hospitals in the context of racial residential segregation. Public Health 182(May):95–101; https://doi.org/10.1016/j.puhe.2020.02.004 . PMID: 32213360.
View Abstract
Publication: Manuscripts
Stalbovskaya V, Wasserman E, Fryzek J, Bylsma L , Sirulnik A. NRG1 fusion-driven cancers: A systematic literature review and meta-analysis. Abstract, Annual Meeting of the American Society of Clinical Oncology, May 2020.
View Abstract
Publication: Abstracts and Presentations
Bylsma LC , Dean R, Lowe K, Sangare L, Alexander D, Fryzek J. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics. Poster for Society of Toxicology 59th Annual Meeting, Virtual, 2020.
View Abstract
A Division of